Search Result "urokinase plasminogen activator (uPA)"
Inhibitors of the Proteolytic Activity of Urokinase Type Plasminogen Activator
Journal: Current Pharmaceutical Design
Volume: 9 Issue: 1 Year: 2003 Page: 1483-1498
Author(s): Todd W. Rockway, Vincent L. Giranda
The Urokinase Plasminogen Activator System: Role in Malignancy
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 39-49
Author(s): Michael J. Duffy
Inhibitors of the Protease Domain of Urokinase-Type Plasminogen Activator
Journal: Current Pharmaceutical Design
Volume: 8 Issue: 2 Year: 2002 Page: 2541-2558
Author(s): T. W. Rockway, V. Nienaber, V. L. Giranda
Urokinase-type Plasminogen Activator (uPA) and its Receptor (uPAR): Development of Antagonists of uPA / uPAR Interaction and their Effects In Vitro and In Vivo
Journal: Current Pharmaceutical Design
Volume: 9 Issue: 1 Year: 2003 Page: 1529-1543
Author(s): Ute Reuning, Stefan Sperl, Charlotte Kopitz, Horst Kessler, Achim Kruger, Manfred Schmitt, Viktor Magdolen
Urokinase Type Plasminogen Activator and the Molecular Mechanisms of its Regulation in Cancer
Journal: Protein & Peptide Letters
Volume: 24 Issue: 10 Year: 2017 Page: 936-946
Author(s): Juan F. Santibanez
The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 1 Year: 2011 Page: 1944-1961
Author(s): Maria Vincenza Carriero, Maria Patrizia Stoppelli
The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Journal: Current Cancer Drug Targets
Volume: 9 Issue: 1 Year: 2009 Page: 32-71
Author(s): Salvatore Ulisse, Enke Baldini, Salvatore Sorrenti, Massimino DArmiento
The Urokinase Plasminogen Activation System in Rheumatoid Arthritis: Pathophysiological Roles and Prospective Therapeutic Targets
Journal: Current Drug Targets
Volume: 20 Issue: 9 Year: 2019 Page: 970-981
Author(s): Benjamin J Buckley,Umar Ali,Michael J Kelso,Marie Ranson
Novel Patents and Cancer Therapies for Transforming Growth Factor- Beta and Urokinase Type Plasminogen Activator: Potential Use of Their Interplay in Tumorigenesis
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 9 Issue: 3 Year: 2014 Page: 354-371
Author(s): Jelena Krstic,Irina Maslovaric,Juan F. Santibanez
Plasminogen Activator System and Vascular Disease
Journal: Current Vascular Pharmacology
Volume: 4 Issue: 2 Year: 2006 Page: 101-116
Author(s): Suzanne M. Nicholl, Elisa Roztocil, Mark G. Davies